TESSA DANIELS: Open Payments
NPI 1700370087 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 38 payments from 8 companies in 2025. Trend: 2023 $880 · 2024 $345 · 2025 $883
Food & beverage: $874Education: $9
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $343 |
| ABBVIE INC. | 14 | $314 |
| Lilly USA, LLC | 1 | $77 |
| PFIZER INC. | 4 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| GENZYME CORPORATION | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $9 |
Products named: TREMFYA, SKYRIZI, OMVOH, RINVOQ, XELJANZ, XIFAXAN, MAVYRET, ZENPEP.
Industry payments across OR — which companies pay providers there.
